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ABSTRACT 
 
Knowledge regarding the kinetics of metastatic tumor 
formation, as related to the growth of the primary tumor, 
represents a fundamental issue in cancer biology. Using an 
in vivo mammalian model, we show here that one can 
obtain useful information from the frequency distribution 
of the sizes of metastatic colonies in distant organs after 
serial sectioning and image reconstruction. To explain the 
experimental findings, we constructed a biophysical model 
based on the respective growth patterns of the primary 
tumor and metastases and a stochastic process of 
metastatic colony formation. Heterogeneous distributions 
of various biological parameters were considered. We 
found that the elementary assumption of exponential forms 
of growth for the primary tumor and metastatic colonies 
predicts a linear relation on a log-log plot of a metastatic 
colony size distribution, which was consistent with the 
experimental results. Furthermore, the slope of the curve 
signifies the ratio of growth rates of the primary and the 
metastases. Non-exponential (Gompertzian and logistic) 
tumor growth patterns were also incorporated into the 
theory to explain possible deviation from the log-log linear 
relation. The observed metastasis-free probability also 
supported the assumption of a time-dependent Poisson 
process. With this approach, we determined the 
mechanistic parameters governing the process of 
metastatogenesis in the lungs for two murine tumor cell 
lines (KHT and MCaK). Since biological parameters 
specified in the model could be obtained in the laboratory, 
a workable metastatic "assay" may be established for 
various malignancies and in turn contribute in formulating 
rational treatment regimens for subclinical metastases. 
 
INTRODUCTION 
 
Metastatic formation in a cancer patient represents a 
detrimental event despite the advancement of localized therapy 
for the primary disease. Since modern diagnostic technology 
still leaves much to be desired for the detection of metastases, 
the oncologists often effect a “prophylactic” treatment strategy 
for the presumably undetected metastases (defined as 
micrometastases, or subclinical metastases). So far, the clinical 
practice has been based mainly upon empirical observations 
(1). More recently, statistical analysis of clinical data has 
implicated the usefulness of low-dose radiation therapy 
previously thought to be ineffective for the control of 
subclinical disease (2). In order to provide a rational basis in 
designing treatment regimens for subclinical metastases, we 
aim to construct a mechanistically oriented quantitative theory 
describing the metastasis process, and test its validity with in 
vivo mammalian experimentation. We wish to modify our 
theoretical model in a controlled fashion by adding complexity 
one step at a time. The ultimate aim is to develop a plausible 
mathematical model that reflects reality as much as possible, 
yet complexity should be minimized so that it is practical. The 
particular model could be rendered implausible easily by 
contradictory data, but the methodology should remain 
incorruptible. 
Therefore, with regard to the metastatic problem, we 
hypothesize that, in general, the relative sizes of metastatic 
colonies in a distant organ reflect the temporal order of their 
initial arrivals, while the size-specific numerical frequencies 
correlate directly with the primary tumor bulk at the time of the 
metastatic “shedding”. In such way, the information leading to 
the kinetic relationship between the primary tumor and its 
metastatic progenies is “archived” as the metastatic colony size 
distribution, dictated by their respective growth behaviors and 
the probability of the metastatic events. 
 
MATERIALS AND METHODS 
 
In Vivo Murine Experiment 
 
Animal Preparation and Tumor Cell Lines. C3H female mice 
from the specific pathogen free animal colony in the Experimental 
Division of the UCLA Department of Radiation Oncology were used 
in the in vivo experiments. When necessary, the animals were 
anesthetized via intraperitoneal injection of Nembutal (62.5 mg/kg). 
They were maintained in cages and in accordance with the UCLA 
animal protection guidelines. Two different murine tumor cell lines, 
KHT (sarcoma) and MCaK (breast cancer), were used. 
Ascertain Growth Behavior of Primary Tumors. Each mouse 
was inoculated with a fixed amount of tumor cells subcutaneously at 
its flank. The sizes of the primary tumors were monitored serially in 
time by measuring the length, width, and depth of each palpable 
tumor with micrometer, and multiplying all three to obtain the 
volume. The “average diameter” was arbitrarily set to be the cube root 
of this volume - we elected not to account for the shape of the tumor 
and likewise assumed that the volume calculated is related directly to 
the number of clonogenic cells, and ignored the possible existence of 
a necrotic portion in which the cells were most likely dead. The graph 
of the primary tumor volume was plotted against time after the first 
measurable nodule occurred (around 3-mm average diameter), since 
the time from tumor cell inoculation to the first appearance of 
palpable tumor was seen to vary widely. 
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Obtaining Metastatic-free Probability Curve. After primary 
tumor implantation, the sizes of the primary tumors were measured 
and the average diameter obtained as described above. All mice 
underwent surgical resection of their primary tumor after the tumor 
grew to a pre-set size, randomly assigned to different categories of 6, 
7, 8, 9, 10, 11, 12, 14, 16 cm average diameter. However, the actual 
size of each tumor upon resection was measured, and the final 
averaged value was obtained for that size category (bin) when 
calculating the frequency of metastasis for that particular bin. The 
animals were then allowed to live either to imminent death or up to 
100 days post implantation, at which time they would be sacrificed 
(except those assigned to the experiment described in the next 
paragraph). Only mice with no sign of local recurrence of its primary 
tumor were included in the subsequent analysis. Upon their death, the 
lungs of these animals were surgically excised and fixed in Bouin’s 
solution, which enabled direct visualization of metastatic colonies 
under low-power magnification. If no tumor colony was visible at all, 
the animal was considered operationally to be free of any metastasis at 
the time of the primary tumor excision. A MFP3 curve as a function of 
the size of primary tumor, N, was thus generated. 
Obtaining Metastatic Colony Size Distribution. In this 
experiment, mice underwent resection of their primary tumor after it 
grew to a designated size, then sacrificed at pre-set number of days 
after the surgery; some were allowed to keep the primary tumor in situ 
until spontaneous death or sacrifice. Only mice with no sign of local 
primary tumor recurrence were included in the subsequent analysis. 
Upon death, the lungs of all animals were surgically excised and fixed 
in formalin, paraffin-embedded and stained with hematoxylin and 
eosin. Serial slide sections of 5-µm thickness were then obtained and 
examined meticulously under high-power microscope. Contiguous 
cross-sections of individual metastatic colonies were traced and their 
areas obtained via digital imaging technique, described as follows: A 
video camera (Javelin CCD camera, Javelin Electronics, Torrance, 
CA) is attached to a microscope equipped with multiple power fields. 
Each slide was scanned in a raster motion manually, and all visible 
metastatic colonies (up to the highest power field) were identified. 
The video images were captured by a frame grabber (Oculux TCX, 
Coreco Inc., St-Laurent, Quebec), and the digitized data sent to a 
computer. Using image analysis software (Optimas software, 
BioScan, Inc., Edmonds, WA) that allows one to quantify the area of 
an enclosed region traced on the digitized image, the areas of the 
cross sections of all colonies were obtained for each slide. These 
results were submitted to the computer and stored in a data base 
spreadsheet. Volumes were then computed by "stacking" the images 
for each metastatic colony in contiguous sections, summing the 
corresponding cross-section areas, and multiplying the slide 
thickness. In such fashion, a histogram of the volume distribution of 
metastatic colonies was obtained. 
 
Mathematical Model 
 
General Approach. After formulating a hypothesis based on 
biophysical argument, the resulting mathematical expression is solved 
analytically to obtain a closed-form solution specifying the 
quantitative relationship between the variable in question and various 
biophysical parameters. If an analytical solution cannot be obtained, 
numerical simulation is performed (Mathcad 8, MathSoft, Inc., 
Cambridge, MA). Fittings of data with the theoretical formulas are 
done via non-linear regression algorithm (STATISTICA software, 
StatSoft, Inc., Tulsa, OK). 
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 The abbreviations used are: MFP, metastasis-free probability; MFSP, 
metastasis-free survival probability; MCP, metastasis control probability. 
Metastatic-free Probability. We begin with the most 
elementary assumption that both the primary tumor and the metastatic 
colonies grow exponentially, with parameters λ and µ characterizing 
the respective growth rates. Next, we focus on quantifying the 
probability of the eventual establishment of the metastatic colonies, 
since studies using intravital videomicroscopy has suggested that the 
rate-limiting step in the post-vascular phase of the “metastatic 
cascade” to be at the final growth stage in the destined organs (3). 
Furthermore, the endpoints, which bypass the entire chain of events 
after the cancer cells detach from the primary tumors until they start 
to grow in the distant organs (effectively treating such multi-steps as a 
“black box”), are of primary clinical significance after all. Since the 
process of metastatic colony formation is known to be very inefficient 
(4), we assume such probability to be very small, although at any 
moment it is in direct proportion with the primary tumor size. Finally, 
we expect the numbers of these events occurring in disjoint time 
intervals to be independent. Mathematically, these assumption are 
equivalent to stating that the probability of establishing a metastatic 
colony follows a nonhomogeneous Poisson process (5) with an 
“intensity function” in proportion to N(t), the primary tumor size. The 
proportional constant, termed η, thus represents the rate of metastatic 
colony formation, or metastatic rate for short, and has a dimension of 
number of colonies formed per time per primary tumor cell / size. It is 
another biological parameter defined precisely in this model and 
corresponds to the crudely described “metastatic potential” in clinical 
oncology. Hence, we find4 
( ) ( ) ( )[ ]{ }0exp)( tNtNtMFP −−= λη ,    (1) 
where t0 is the starting time of the Poisson process. Eq. (1) predicts 
MFP to follow a sigmoid curve when plotted as a function of the 
logarithm of N (i.e., time t, assuming exponential primary tumor 
growth: N(t) = N0eλt, where N0 is the size of the primary at t = 0). On 
a plot of lnMFP vs. N, a linear function is expected with a slope 
dictated by the ratio η/λ. However, if we incorporate heterogeneity 
into η by assuming it to be normally distributed among a population 
cohort with a mean, η0, and variance, 2ησ , it can be found that
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( )[ ] ( )[ ]202200 )()(2)()(~)(ln tNtNtNtNtMFP −+−− λσλη η    (2) 
Metastatic Colony Size Distribution. Fig. 1A shows the rather 
heuristic argument why the theoretical metastatic colony size 
distribution curve can be a straight line on a log-log plot, if both the 
primary tumor and all the colonies grow exponentially at constant 
rates. We wish to explore the biological meaning of this curve, i.e., 
expressing its slope in terms of the biological parameters specified in 
the mechanistic model.  Define R(m,t) as the number of distinct 
metastatic colonies per size m at time t (thus called “size density 
function”, the integral of which over the m-axis gives the total number 
of colonies at time t). If each metastatic colony grows with a constant 
rate of µ, we can formulate a partial differential equation4: 
( ) ( )[ ] mtmmRttmR ∂∂−=∂∂ ,, µ . 
With appropriate initial conditions, the solution is given as 
( ) κλµη meNtmR t0),( = ,     (3) 
where κ = -[(λ/µ)+1)] is the slope of the straight line on a lnR vs. lnm 
plot. If the heterogeneity in µ is considered with a mean value of µ0, a 
straight line also results on a log-log plot, with the slope governed by 
-[(λ/µ0)+1)] as a leading-order approximation. This is derived in 
detail by assuming µ to be either normally distributed among all 
metastatic colonies or subject to random fluctuations in time, with µ0 
as the mean metastatic growth rate. In both scenarios, we again find a 
linear relationship (to a first-order approximation, at least) on a log-
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log plot, with the slope κ as a function of λ and µ0.4 It is feasible to 
obtain the solutions for the complicated theoretical equations dealing 
with heterogeneous µ whether numerically or via analytical 
calculation. Biologically meaningful parameters (i.e. the slope) can 
still be inferred readily. Finally, analytical solutions for R(m,t) are 
also found separately using Gompertzian and logistic growth models 
for the primary tumor.4 
In practice, when we obtain laboratory or clinical data, it is 
usually the number of colonies within a particular range of size that 
we possess. Such “size frequency distribution”, F(m,t), can be derived 
from the above-mentioned size-specific “density”, R(m,t), to show: 
( ) µλλµη −=≡ meNtmmRtmF t0),(),( .  (4) 
That is, when plotted on lnF vs. lnm, the slope of lnF(m,t) differs 
from that of lnR(m,t) by -1. When plotted on a semi-log graph against 
lnm, it should reflect an exponential distribution (5), with the 
parameter λ/µ. 
When the primary tumor is excised successfully, one would 
expect the subsequent metastatic colony size distribution to be altered 
in time as established metastases grow but no new ones are created 
(Fig. 1B). Using the most elementary assumption of a uniform growth 
rate, µ, for all colonies, we can figure out the evolutionary course of 
R(m,t) in time. Specifically, if we define tEx as the time the primary 
tumor is excised, then, at time t (t > tEx), we would expect the smallest 
metastatic colonies to result from the growth of metastatic cells which 
begin at time tEx, thus having a size (defined as ma(t), a function of t) 
described by )()(ln Exa tttm −= µ , where we assume that all colonies 
begin to grow as a single cell (i.e. 1)( ≡Exa tm ). Furthermore, the 
number of these smallest colonies is seen to be preserved in time, 
while each continues to grow exponentially at a uniform rate. 
However, if growth rates among metastatic colonies are not uniform, 
one can expect the persistent presence of colonies with size smaller 
than ma(t). 
 
RESULTS 
 
Primary Tumor Growth Behavior. In a pilot 
experiment, 2 x 105 MCaK cells were inoculated in 119 mice, 
and the growth curve was subsequently obtained. Fig. 2A 
shows the growth curve, with the primary tumor size as a 
function of time after the first measurable tumor appears. The 
growth resembles exponential pattern for the early and major 
portion of its history (dark symbols). The solid curve comes 
from fitting this portion of the observed data for the early 
growth with the theoretical prediction based on the exponential 
model. The averaged growth rate was found to be 
approximately 0.25 day-1, or a tumor doubling time of 2.8 days. 
Fig. 2B shows the growth curves for a second experiment with 
150 mice, each implanted with 3 x 105 MCaK cells, with 
averaged growth rate at the early, exponential phase found to 
be approximately 0.18 day-1, or a tumor doubling time of 3.9 
days. Apparently, both sets of data showed significant 
deviation from the exponential pattern toward the later phase of 
the tumor growth (open symbols), consistent with growth 
retardation. This demonstrates the inadequacy of the 
exponential model to describe the entire history of the tumor 
growth. In fact, fitting with logistic and Gompertzian functions 
for the entire set of data points were done, and more 
complicated biological parameters were obtained accordingly 
based on our theoretical models.4 
Metastatic-free Probability Curve. For the 150 mice 
implanted with 3 x 105 MCaK cells, all were randomly 
assigned to undergo surgical resection of their primary tumor at 
pre-set sizes. After excluding those with local recurrences and 
other causes (premature death of unclear cause, loss of 
identification tag on the animal's ear, etc.), a total of 106 
animals were eligible for this part of the experiment. Fig. 3A 
shows the MFP as a function of the average primary tumor 
volume actually measured within each assigned size-category 
(with the number of animals in each category varied from 9 to 
18), but on a logarithmic scale (thus corresponding to time-axis 
linearly). A monotonically decreasing sigmoid curve is seen 
with the inflection point occurring at a primary tumor size of 
870 mm3. Fig. 3B is generated based on the same data, but 
presented as lnMFP vs. N, the primary tumor volume. One can 
see that the data appear to fit better a linear-quadratic function, 
which is consistent with a theory based on a normally 
distributed η (Eq. (2)). Recall that the primary tumor growth 
rate (λ) for this cohort of mice was found to be 0.18 day-1 (Fig. 
2B). From Fig. 3B, we obtained η0/λ = 1.15 x 10-3 mm-3. Thus, 
the mean metastatic rate (η0) can be calculated to be 2.07 x 10-
4 d-1mm-3, and the standard deviation, ση, for the presumed 
Gaussian heterogeneity in η is 9.3 x 10-5 d-1mm-3.  If one 
assumes that a tumor of 1 cm3 contains about 109 cells, then η0 
becomes 2.07 x 10-10 per day per cell. That is, for MCaK 
tumor, this translates to approximately an average of 1.15 
metastatic events per 109 cells (1 cm3) of primary tumor. This 
does not mean that there is 1.15 metastatic events in every 30 
doublings (since 230~109) of the primary tumor. It merely 
means that, for a large number of animals each with a primary 
tumor of 109 cells, while some might have no metastasis at all, 
others would have experienced 1, 2, 3 ... to an essentially 
infinite number of such events. Overall, there is on the average 
1.15 metastatic events which have occurred for each animal. 
One can see that such notion as "metastatic potential" is quite 
crude, and thus we do not advocate its use. In contrast, the 
“metastatic rate”, η, as defined operationally in our model, 
possesses a clear, mechanistic, meaning, and perhaps should be 
employed routinely for the quantification of the metastatic 
tendency of a particular malignancy. 
Metastatic Colony Size Distribution. A subset of mice 
transplanted with 2 x 105 KHT or MCaK tumor cells were 
sacrificed with primary tumor in place (in situ), and their lungs 
harvested for the purpose of constructing the metastatic colony 
size distribution curve. Those designated to undergo excision 
of their primary tumors at approximately 10 mm average 
diameter were sacrificed at 0, 1, 4, 6, 8, 12 days post-resection 
of their primary tumors. As the procedure involved in obtaining 
the colony size distribution for each animal was quite tedious, 
and the purpose of the study was for validation of principle, 
data based on only a few mice was obtained. Here we present 
the result for a mouse injected with KHT cells without primary 
tumor excision, and two mice injected with MCaK cells with 
primary tumor excision at 10 mm average diameter and 
sacrificed at 6 days and 12 days post-surgery, respectively. 
For the mouse with KHT inoculation and without primary 
tumor excision, a total of 277 metastatic colonies were found, 
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with size ranging from minimum of 1.76 x 10-6 mm3 to 
maximum of 3.47 mm3. Fig. 4A shows the histogram display of 
the number of colonies distributed among 21 bin categories 
plotted on a natural logarithmic scale. When the data are 
presented in such a semi-log fashion, they appear to follow the 
theoretical curve based on the prediction of Eq. (4), i.e. an 
exponential distribution (solid curve). A parameter of 0.16 was 
found. The dashed curve corresponds to an exponential 
distribution extrapolated retroactively after fitting a log-log 
plot with a linear function (logF(m,t) in Fig. 4B), with the ratio 
λ/µ found to be 0.25, consistent with micrometastases growing 
4 times faster than the primary. 
To follow closely how much the data points deviate from 
the theoretical prediction, the residuals for lnR(m,t) are plotted 
in Fig 5A. We see that deviation occurs predominantly at both 
extremes of the small and the large size categories. Figs. 5B 
and 5C show the results of fitting of the size density function 
with Gompertzian and logistic models for primary tumor 
growth, respectively. Indeed, better fitting of the data points 
can be achieved with these kinds of non-exponential primary 
tumor growth, with the expected more complex form of 
biological parameters specified in these models (each with one 
more parameter than the exponential model). 
Fig. 6 shows the result of the two mice implanted with 
MCaK cells, which then underwent primary tumor excision at a 
size of 10.2 mm and 10.5 mm average diameter, respectively. 
The first mouse was allowed to live another 6 days, and the 
second 12 days, until they were sacrificed. The growth curve 
for the individual primary tumor, from the time it became 
palpable until it was excised, was obtained in both cases, and 
the growth rates were found to be approximately identical: λ = 
0.27 d-1. One can see from Fig. 6 that their individual 
metastatic colony size distribution appears to contain two 
phases. The solid symbols in both curves represent the linear 
size distribution of the larger metastatic colonies and reflect the 
kinetics of metastatogenesis prior to the excision of the primary 
tumor, similar to the schematic drawing of Fig. 1B. We may 
use this portion of the curve to extrapolate the metastatic 
growth rate, µ, for either mouse. For the first, it is calculated to 
be 0.66 d-1, and for the second, 0.29 d-1 (corresponding 
respectively to tumor doubling time of 1.0 d and 2.4 d). Even 
though there were 6 more days of waiting for the second mouse 
to be sacrificed, its slower growth rate apparently offset such 
difference, since the expected positions on the abscissa of the 
log-log plot for the left-most end-points of the truncated 
lnR(m,t) lines (numerically equals to )()(ln Exa tttm −= µ ; see 
also Fig. 1B) turned out to be similar for the two mice (3.96 
and 3.48, respectively, equivalent to the smallest metastases 
having grown to contain about 52 cells and 32 cells). In fact, if 
we adhere to our assumption that 1 cm3 of tumor represents an 
aggregate of 109 cells, then a single cell would be about 10-6 
mm3, of which the logarithm would be -13.8. The values of ma 
for the two mice determined above would thus be 5.2 x 10-5 
mm3 and 3.2 x 10-5 mm3 (the logarithm would be -9.9 and -
10.3, respectively). We can see from Fig. 3.15 that there was 
indeed an absence of smaller colonies in either mouse, ranging 
from single cell to about 45 cells (or 4.5 x 10-5 mm3, of which 
the logarithm is -10), which agrees somewhat with the values 
of ma estimated above. 
The rough calculations done so far, and likewise the 
“hand-waving” arguments used in Figs. 1A and 1B, pertain to 
the ideal assumption that all metastatic colonies within the 
same mouse grow at a uniform rate. Our experimental data can 
be interpreted to show otherwise, i.e. that the growth rates of 
the colonies are heterogeneously distributed and the value of µ 
found is at best an average, since clearly “truncated” straight 
lines for the size distributions were not obtained for the two 
animals that underwent primary tumor resection. Some 
colonies of smaller sizes (open symbols in Fig. 6) apparently 
got "left behind", failing to grow bigger as predicted based on a 
uniform µ. 
 
DISCUSSION 
 
Primary Tumor Growth Behavior. In our murine 
experiments, there was evidence that growth retardation of the 
primary tumors occurred mainly at a relatively late stage. 
Biological reasons for such behavior include lack of nutrition 
or oxygen, or some kind of negative feedback control in 
operation. When the entire set of data points for both 
experiments were used for fitting with theoretical growth 
models, a satisfactory result could be obtained for either 
logistic or Gompertzian model (with the former showing the 
best outcome). They might even warrant a more complicated 
description of the whole growth process, such as a “Gomp-ex” 
pattern advocated by Wheldon (6), or a two-phase stochastic 
model analyzed by Zheng (7). However, one must note that 
there were significant statistical and experimental errors for 
tumors of larger dimension (open symbols in Figs. 2A and 2B), 
which were not only few in number but each also contained 
massive central necrosis. Furthermore, fitting with non-
exponential functions in general requires more parameters than 
that for an exponential form, which would introduce more 
degrees of arbitrariness into our theoretical model. This defies 
our purpose of maintaining as simple as possible our 
mechanistically oriented model, according to Occam’s Razor. 
Most importantly, the primary purpose of our experimentation 
is to investigate the kinetics of subclinical metastatic 
formations, which occur mostly over the early major portion of 
the total growth duration of the primary tumor. We have shown 
in our animal experiment that such early primary growth can be 
modeled fairly well with the exponential form, from which the 
numerical value of λ can be extracted. For MCaK tumors, for 
example, the averaged growth rate for the initial 20 days or so 
after palpable tumors first appear was found to be 
approximately 0.18 to 0.25 day-1, or a tumor doubling time of 
2.8 to 3.9 days. The possible effect of heterogeneity in λ, as 
modeled using non-negative Gaussian distribution, did not 
seem significant after numerical simulations using a wide range 
of variance. 
Metastatic-free Probability Curve. Ubiquitous in nature, 
Poisson process has been used by several investigators in 
explaining the process of metastasis, albeit at different stages in 
the cascade and with various biological assumptions (8-12). 
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Our formulation predicts the probability of remaining free of 
any metastasis, MFP, to follow a sigmoid curve when plotted 
as a function of the logarithm of primary tumor size, N (Eq. 
(1)). This was supported by the experimental data (Fig. 3A). 
The tumor size (around 870 mm3 for MCaK cells) at which the 
MFP decreases sharply (i.e. the inflection point of the curve) 
will be governed by both primary tumor growth rate, λ, and 
metastatic rate, η, which may actually depend on time as well 
as vary among different individuals in a population. Indeed, 
when plotting a curve of lnMFP vs. N for the case of constant 
η, a linear function is expected. Our experimental observation, 
however, agrees better with the prediction when η is assumed 
to be normally distributed among the population cohort (Eq. 
(2), Fig. 3B), a reasonable biological assumption. In such a 
case, an additional quadratic effect is found due to the variance 
of η, so that lnMFP actually has a slower rate of decline as N 
increases. By numerical simulation, the overall effect of 
heterogeneous η on a MFP vs. lnN plot can be shown to make 
the sigmoid curve a bit “flatter”. 
That a graph of MFP vs. lnN should give rise to a sigmoid 
curve as predicted by our model may not be apparent when one 
examines clinical data. For example, Thames et al. (12) and 
Koscielny et al. (13-15) all presented statistical analyses of 
human breast cancer data and provided some illustrations of 
metastatic probability as a function of primary tumor size. The 
three-parameter maximum-likelihood fitting of the data by the 
former group and the log-probit representation by the latter 
have yielded useful information. In this paper we are concerned 
about the probability of no metastasis at all (MFP), as 
governed by our assumption of a Poisson process of metastatic 
colony establishment. Our experimental result was similar to 
the laboratory observation by Liotta et al. (8, Figure 5). 
We have also obtained reasonable agreement between our 
approach and the statistical analysis of Koscielny et al. (13) for 
a set of MFP data. These investigators presented their analysis 
of 2684 breast cancer patients at Institut Gustave Roussy and 
gave a set of clinical data pertaining to MFP, which were 
extracted from a collection of metastasis-probability vs. time 
curves for different primary tumor sizes at initial treatment 
(Figure 1 in their paper). By extrapolating the eventual 
leveling-off levels of these curves back to the time of the initial 
treatment, a table was generated for “proportions of initiated 
metastases” (one minus which would be MFP) as a function of 
the tumor size (Table I in their paper). In this table, two sets of 
data were given: one from actuarial curves, the other from an 
assumption of a “lognormal” model. We fitted the part 
obtained from the actuarial curves with our theoretical 
expression of Eq. (2), and found that the ratio of the mean of 
metastatic rate, η0, to the primary tumor growth rate, λ, to be 
about 0.018 cm-3. Since these authors claimed the median 
tumor doubling time to be about 7 months (Table I in Ref. 14) - 
thus corresponding to λ of about 0.1 mon-1 - the mean 
metastatic rate turned out to be about 0.0018 mon-1 cm-3 per 
our analysis. Furthermore, from this ratio and Eq. (2) (and 
noting that N(t0) is relatively negligible), we could determine 
the tumor size at which MFP decreases to 50%, N(t0.5), which 
turned out to be 38.5 cm3. This value is comparable in 
magnitude with what the authors called the median “threshold” 
volume of 23.6 ml (95% confidence range from 0.14 to 4000 
ml), after their log-probit analysis. 
Metastatic Colony Size Distribution. We have shown the 
feasibility of extracting the growth rate of metastases, µ, from 
size-distribution of the metastatic colonies (given as the 
frequency distribution, F(m,t), or the size density function, 
R(m,t)). In the case of constant µ, and assuming exponential 
growth for both primary tumor and the metastatic colonies, Eq. 
(3) is obtained, and predicts for a straight line on a graph of 
lnR(m,t) vs. lnm. More importantly, the slope of this line can 
tell us something about the biological parameters set forth in 
our quantitative model: it reflects the ratio of the growth rates 
of the primary tumor and the metastases. This is one of the true 
merits of our “mechanistically” oriented model. 
That a straight line is often an artifact introduced by a 
representation using log-log plot is not a valid criticism of our 
model here (it would be if all we do were to fit a straight line 
statistically upon the data, without caring about its biological 
meaning). Note that the frequency distribution depicted as the 
number of colonies counted over a specific bin size (thus given 
as F(m,t), or mR(m,t)) gives rise to an exponential distribution 
when plotted against lnm (Eq. (4)). The same biological 
information can thus be obtained from a semi-log plot of F(m,t) 
vs. lnm (Fig. 4A, cf. Fig. 4B).  
Hence, the value of the metastatic growth rate, µ, which is 
largely unknown whether in laboratory or clinical settings, can 
be inferred using this model if the primary tumor growth rate, 
λ, is known. The more realistic case of non-uniform metastatic 
growth rate has also been considered, and we again find a 
linear relationship (to a first-order approximation) on a log-log 
plot, with the slope dictated by the ratio λ/µ0. Thus, from Fig. 
5A, this ratio for KHT cells was found to be 0.24 (i.e. an 
average growth rate of micrometastases which is about four 
times faster than the growth rate of the primary tumor), yet the 
phenomenon of a heterogeneous µ was not conspicuous in such 
an experiment. 
On the other hand, we also excised the primary tumors at 
certain sizes from a subset of mice and removed their lungs at 
different time periods post-excision. Their individual 
metastatic colony size distribution appeared to contain two 
phases, as exemplified in Fig. 6 for MCaK cells. The solid 
symbols represent the linear size distribution of the larger 
metastatic colonies and reflect the kinetics of metastatogenesis 
prior to primary tumor excision. The open symbols in Fig. 6 
correspond to smaller colonies, which may have resulted from 
their slower growth rates because, in all cases they must have 
been established before the excision, thus implying indirectly 
that the metastatic growth rates are not uniform. 
Nevertheless, non-uniform metastatic growth rates might 
not be the only plausible explanation for Fig. 6. Note that the 
values of ma for the two mice as determined fall very close to 
the theoretical prediction based on an uniform µ for either 
animal. Furthermore, both values correspond to the size of the 
smallest colonies at the left-end of the open symbols, instead of 
the solid ones from which the straight lines are extrapolated. In 
either case, therefore, the deviation of the open symbols from 
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the straight line may be a reflection of shortage in numbers of 
these smaller colonies rather than a consequence of their 
slower growth. This shortage in numbers cannot be attributed 
solely to our inability to detect and score the smaller metastatic 
colonies because, as already shown in our earlier experiment 
using the mouse without primary tumor excision, we are quite 
capable of identifying some extremely small colonies with our 
image analysis technique. We may have missed some, but not 
likely all of them. Thus, all metastatic colonies within the same 
animal could have grown at a relatively uniform rate, but some 
mechanism (perhaps as a consequence of the primary tumor 
excision) might have existed to exert an inhibitory effect on 
relatively smaller colonies preferentially. 
When the graph of residuals (i.e. the difference of each 
data point from the theoretical prediction) of our metastatic 
colony size distribution for the KHT tumor is plotted (Fig. 4A), 
it appears that there is a systematic deviation from the straight 
line towards the logarithmically smaller sizes. Although there 
may be some underscoring of these minute micrometastases, 
the deviation is consistent with the fact that the theoretical 
curve is based on exponential tumor growth, whereas the 
primary tumor may instead approach a significant plateau 
during its late growth stage. While this may also explain 
partially the pattern of the open symbols in Fig. 6 for the case 
of MCaK primary tumors which were excised off the two 
animals, we note that their size at excision (about 1000 mm3) 
corresponded well within the early exponential phase of the 
growth, as can be inferred from Fig. 2. At any rate, while we 
also have analytical solutions for the colony size distribution 
for non-exponential growth patterns of the primary tumor, there 
are other possible explanations for deviation from a straight 
line at smaller sizes, including: 1. Some biological mechanisms 
exist to eliminate the small metastases preferentially, 2. Some 
smaller metastases fail to grow further because they have an 
intrinsic growth rate limitation (which is insensitive to the 
consideration of a normally distributed µ), 3. Experimental 
errors (small metastatic colonies are simply harder to detect), 
and 4. Secondary metastases from pre-existing metastases 
(which may in fact increase the number of the smaller 
metastases, but is extremely unlikely given the metastatic 
inefficiency characteristic of the primary tumor). These factors 
may not be totally independent, and any experimental attempt 
to determine their individual contribution must control well the 
possible confounding variables. When a specific biological 
factor is considered relevant, our mathematical model can be 
modified accordingly. This may necessitate more complicated 
analytical formulations, but can be quite feasible using modern 
computers for numerical results. 
When taking into consideration non-exponential primary 
tumor growth by using the Gompertzian and the logistic 
models, we also obtain the analytical expressions for the 
colony size distribution, which depend explicitly on the 
mechanistic parameters in question. Both appeared to describe 
the laboratory data well (Figs. 5B and 5C). Kinetic parameters 
governing the metastatic process can thus be determined from 
the colony size distributions. In this way, the animal model 
could potentially be utilized as an “assay” method to quantify 
the metastatic potential of different malignant cell lines. 
The quantitative model developed may also be applied in 
the clinical setting if one obtains the “volume” distribution of 
metastases from diagnostic imaging studies of cancer patients. 
Iwata et al. (16) have published a study with the metastasis size 
distributions obtained from clinical tomographic images, taken 
sequentially in time for a patient with a hepatocellular 
carcinoma and subsequent multiple intra-hepatic metastases. 
These investigators apparently considered the original primary 
tumor to be an entity distinct from the subsequent appearances 
of multiple tumors within the same organ (liver), and treated 
these lesions as its bona fide metastatic progenies. With such 
proviso, we have tried to explain their data with our own model 
and extract the biological parameters as specified. Their data 
were fitted with our model based on Gompertzian (perhaps 
more appropriate for these relatively large, clinically-detected 
lesions) as well as exponential growth patterns for the 
metastases. Biological parameters were obtained for both. In 
the analysis by Iwata et al. themselves, Gompertzian growth 
model for the tumors (both the primary and the metastases) was 
used, although discussions regarding exponential and power 
laws of growth were also given (16). However, they considered 
the primary tumor and its metastatic progenies to have identical 
growth rates and behavior. This was perhaps appropriate for 
the particular clinical example they tried to model, namely, 
with both primary and metastases being in the same organ. 
They further included additional complexities empirically, such 
as a fractal dimension of the tumor size (thus shedding of 
metastases from only the surface of the primary tumor could be 
considered), and secondary metastases from metastases 
themselves. In contrast, our model allows one to distinguish the 
probably existing differences between the growth behaviors 
(both the pattern and its associated parameters, e.g. the rate of 
growth) of the primary tumor and its metastases. For example, 
using the exponential model, we found λ/µ, from their size-
distribution data on post-diagnosis day 432, 559, and 632, to 
be 0.57, 0.60, and 0.68, respectively. That is, the ratio between 
the primary to average metastatic growth rates was about 2/3, 
not unity. So far, we have declined adding fractal dimension or 
other modifications of our elementary model to accommodate 
possible tumor structural or physiological factors. Likewise, 
secondary metastases are ignored. We would add these 
complexities beyond our elementary model one at a time, when 
more data from well-controlled experiments are available and 
warrant such endeavors. 
In addition to these main differences between the approach 
of Iwata, et al. and ours, we also need to emphasize that here 
we aim to assess the kinetic relationship between primary 
tumor growth and subclinical metastatic formations. Thus, the 
exponential growth model alone may be adequate for 
describing the early-growth phase of the primary tumor and the 
metastases. Armed with such an elementary theoretical 
construct, we only need to know about relatively few biological 
parameters (i.e. η, λ, and µ), based on which we can now 
elaborate and attempt to model the apparently more 
 7 
complicated, clinically obtained information, as exemplified in 
the subsequent chapters. 
Since the task of obtaining detailed metastatic colony size 
distribution in our experiment is extremely tedious and labor-
intensive, we have begun to develop an algorithm based on 
stereological principles (17-19) to expedite obtaining the size 
distributions in a more efficient manner by sampling two-
dimensional histologic sections of organs involved by 
metastases. The clinical implication of cross-sectional sampling 
of the metastatic colony size distribution is quite obvious, in 
view of the fact that tomographic (i.e. 2-D cross-sectional) 
imaging is ubiquitous in medical diagnostic arena today. On 
the other hand, as computer technology improves, a complete 
set of data pertaining to the 3-D volume distribution of 
metastatic colonies may soon be easy to obtain readily in 
clinical or laboratory settings, thus obviating the need for 
sampling. 
Clinical Applications. We have applied our quantitative 
model constructed so far in the clinical setting. For example, 
we formulated a theoretical expression for the metastasis-free 
survival probability (MFSP), defined as the probability of 
detecting no metastasis using a particular diagnostic technique 
that has a certain limiting resolution, as a function of time after 
the diagnosis of the presumably localized primary tumor. With 
the hypothesized Poisson process and its associated theory of 
waiting-time distribution, we have constructed a model 
correlating clinically observed MFSP data with various 
biological parameters. It is feasible to correlate clinical 
prognostic factors (age, sex, race, etc.) or pathologic findings 
(histologic features, hormonal status, molecular diagnostics 
entities, etc.) with our hypothesized biological parameters 
governing the process of metastatogenesis. In such a way, 
systematic analysis of metastatic behavior for human malignant 
tumors can complement the laboratory assay method 
mentioned above. 
Another example we have explored was using the 
biological parameters specified in our mathematical model to 
determine the metastases dose-response relationship for a 
cytotoxic agent like radiation therapy. It is well-established that 
the tumor control probability (TCP) is related directly to the 
radiation dosage and the tumor cell burden (i.e. total number of 
cells in a tumor), and presents as a sigmoid curve when plotted 
against radiation dosage (20) - a consequence of random cell 
killing. Nevertheless, the relationship between the metastasis 
control probability (MCP) and the dose of prophylactic 
radiation treatment to an anatomical region at risk of 
subclinical metastases has generally remained elusive due to 
the lack of knowledge of the metastatic cell burden, M. Using 
our model, we can determine M directly from R(m,t) and 
express it as a function of the primary tumor size, N, and the 
biological parameters, η, λ, and µ. The resulting plot of MCP 
vs. dose is subsequently found to be a sigmoid curve as well, 
although its steep portion could be “flattened” significantly due 
to the heterogeneity in µ or η for a patient population. Thus, 
the clinical implication of a spread in these biological 
parameters is that relatively small radiation dosage may 
actually be quite beneficial for the treatment of subclinical 
metastases, in contrast to an apparent threshold effect 
introduced by assuming no heterogeneity. The flatter curve 
from assuming such heterogeneity agrees with the conclusion 
of Withers et al. (2) from statistical analysis of clinical data, 
and provides a rational basis for achieving some, albeit 
reduced, benefit from radiation doses less than those 
traditionally preferred for treating subclinical diseases. 
With the advancement in modern molecular biology 
research, our approach can also be utilized to investigate in a 
systemic and quantitative manner the effects of any biological 
factor hypothesized to control the metastatic cascade. Equipped 
with our mechanistic model for metastasis formation, one could 
investigate some hypothetical cases - at least in theory - 
encountered in laboratory or clinical settings. For example, the 
model may allow investigators to analyze what they might 
consider as distinct biological mechanisms in the phenomenon 
of metastasis: one governing the initiation of the metastatic 
process (t0), the second, the rate of such occurrence (η), the 
third, the behavior of the source of the metastases (λ), and 
finally, the growth behavior of the metastases themselves (µ). 
When applying mechanistically oriented model like ours to real 
biological data, one must be careful in the interpretation of the 
results. Nevertheless, the model allows biologists to think 
logically in a systematic and controllable fashion. The interplay 
between the data fitting and the incorporation, modification, or 
elimination of mechanistic parameters within the logical 
framework so established, should constitute a worthwhile 
exercise in the study of the biology of metastasis. 
In summary, we have developed a laboratory animal 
model to ascertain the metastatic behaviors of malignant 
tumors by obtaining the metastasis-free probabilities and the 
colony size distributions. A mechanistically oriented 
quantitative theory has been formulated and appeared to 
explain the experimental and clinical observations well. Such 
mechanistic modeling is gaining momentum in biomedical 
research (21), and oncology is no exception (22). The 
advantage of our approach (rather than an empirically derived 
statistical model based on curve-fitting) is the feasibility of 
obtaining various biological parameters governing the process 
of metastasis. By using the proposed model, different tumor 
types may be systematically assayed to analyze their specific 
metastatic potency, and in turn may allow appropriate 
therapeutic strategy to be planned in the clinical setting. 
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Figure Legends 
 
Fig. 1. Schematic drawing showing that the theoretical metastatic colony size distribution curve to be a straight line on a log-log 
plot, if both the primary tumor and all the colonies grow exponentially at constant rates. Assume the primary tumor to grow 
exponentially to 10 times its original size per equal time interval ii ttt −=∆ +1 , during which each and every metastatic colony 
grows 2 times its original size. Furthermore, assume the metastatic efficiency to be one colony establishment per 100 primary 
tumor cells. Then, in A, the distribution of the number of colonies, depicted as F(m,t), should be a straight line on a logF vs. logm 
display, with the slope governed by the growth rates of the primary tumor and the metastatic colonies. In time, this line should 
“travel” progressively. In B, the primary tumor is excised at time t5. The straight line becomes “truncated” as it travels in time 
towards the right. The left upper “end-point” of each line stays at a constant level of 103, representing the number of the smallest 
colonies, while each colony within this group enlarges in size from 20 at time t5 to 24 at time t9. 
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Fig. 2. Growth curves for primary tumors of two groups of mice:. A, a group of 119 mice implanted with 2 x 105 MCaK cells, and 
B, a group of 150 mice implanted with 3 x 105 MCaK cells. Either curve resembles exponential pattern for the early portion of its 
history (dark symbols), and the dashed curve is generated by fitting these selected data points with an exponential growth model 
(R=0.995 for A, and 0.991 for B). Data points for the larger volumes (open symbols), which were not only few in number but also 
contained massive necrosis, are not included for the curve fitting. 
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Fig. 3. A, semi-logarithmic display of the metastasis-free probability (MFP) for a group of mice implanted with MCaK cells, 
plotted as a function of their primary tumor size, N. The dotted curve is generated by fitting with the theoretical formula of Eq. (1) 
(R=0.934; quasi-Newton method). B, same data but plotted as logMFP vs. N. The solid curve is generated by fitting the data points 
with a linear-quadratic function based on Eq. (2) (R=0.934; quasi-Newton method), using also the numerical values for the linear 
term as obtained from A (dotted curve). 
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Fig. 4. Metastatic colony size distribution in the lungs of a mouse, whose flank was implanted with KHT tumor cells, and 
never underwent primary tumor excision. A, a semi-log display is shown, with the ordinate denoting the number of colonies 
counted, equivalent to the “frequency” function, F(m,t). The data are fitted with an exponential distribution via non-linear 
regression (solid curve; R=0.906, quasi-Newton method). A parameter of 0.16 is found. The dashed curve corresponds to an 
exponential distribution with a parameter of 0.25, obtained retroactively from B.  In B, logarithms of both the frequency function, 
F(m,t), and the size density function, R(m,t) are plotted against lnm, then fitted with a linear function (quasi-Newton method: 
R=0.995 for lnR(m,t), and 0.923 for lnF(m,t)), with the slope found to be -0.25 and -1.24, respectively. 
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Fig. 5. Same data as in Fig. 4, showing only the size density function, R(m,t). A, the curve labeled as residuals shows deviations of 
data points from the fitted theoretical curve. As can be inferred from Figs. 4A & 4B, more deviation at each extreme of the size 
spectrum are seen. B, fitting with a Gompertzian growth model for the primary tumor (R=0.998, Hooke-Jeeves pattern moves 
method). C, fitting with a logistic growth model for the primary tumor (R=0.998, Hooke-Jeeves pattern moves method). 
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Fig. 6. Size density functions for two mice implanted with MCaK cells and excised of the primary tumor when the size reached 1 
cm3, and then sacrificed at 6 (circular symbols) and 12 (diamond symbols) days post-excision, respectively. Only data points over 
the larger volume range (solid symbols) are used to fit the theoretical straight line. Although a clear truncation of a straight line is 
not seen, as many smaller size colonies were observed (open symbols), there was absence of colonies smaller than about 4.5x10-5 
mm3 (corresponding to -10 on the abscissa). 
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